Výsledky vyhledávání - "Ana B Blazquez"

Akademický článek

Synergistic effect between amoxicillin and TLR ligands on dendritic cells from amoxicillin-delayed allergic patients.

Autor: Maria J Sanchez-Quintero, Maria J Torres, Ana B Blazquez, Enrique Gómez, Tahia D Fernandez, Inmaculada Doña, Adriana Ariza, Inmaculada Andreu, Lidia Melendez, Miguel Blanca, Cristobalina Mayorga

Publikováno v: PLoS ONE, Vol 8, Iss 9, p e74198 (2013)

Amoxicillin, a low-molecular-weight compound, is able to interact with dendritic cells inducing semi-maturation in vitro. Specific antigens and TLR ligands can synergistically interact with dendritic cells (DC), leading to complete maturation and mor

Externí odkaz: https://doaj.org/article/f9730b893ec6480996723edd655e0fce

Zobrazit plný text záznamu

Supplementary Fig 2 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Autor: Nina Bhardwaj, Rachel Lubong Sabado, Sacha Gnjatic, Sreekumar Balan, Gustavo Gimenez, Christopher B. McClain, Andres M. Salazar, John Mandeli, Rose Marie Holman, Thomas U. Marron, Patrick A. Ott, Michael Lattanzi, Marcia Meseck, Ana B. Blazquez, Anna Pavlick

Supplementary Fig 2

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::613dfae31ff045cf7f097fd9b820dd3d
https://doi.org/10.1158/2326-6066.22543330

Zobrazit plný text záznamu

Supplementary Table 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Overlapping peptides covering the entire NY-ESO-1 protein

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c627173eb2706be395627a622e3335
https://doi.org/10.1158/2326-6066.22543318

Zobrazit plný text záznamu

Supplementary Figure Legend from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Descriptions of Supplementary Figures 1, 2, and 3, and supplementary table 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b5728b6953f614c7e0a9320cbfea71
https://doi.org/10.1158/2326-6066.22543321.v1

Zobrazit plný text záznamu

Supplementary Fig 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Supplementary Fig 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7680f3d77c52e52f04f20bd56c5e6de7
https://doi.org/10.1158/2326-6066.22543333.v1

Zobrazit plný text záznamu

Data from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Given its ability to induce both humoral and cellular immune responses, NY-ESO-1 has been considered a suitable antigen for a cancer vaccine. Despite promising results from early-phase clinical studies in patients with melanoma, NY-ESO-1 vaccine immu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c85972d6d0007ff4430fc95692a12e
https://doi.org/10.1158/2326-6066.c.6550219.v1

Zobrazit plný text záznamu

Supplementary Fig 3 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma

Supplementary Fig 3

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305b92172d58f506bd5bdecef8ea5d20
https://doi.org/10.1158/2326-6066.22543324

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání